The Impact of ABO Blood Grouping on COVID-19 Vulnerability and Seriousness: A Retrospective Cross-Sectional Controlled Study among the Arab Community

Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. S...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of environmental research and public health Vol. 18; no. 1; p. 276
Main Authors El-Shitany, Nagla A., El-Hamamsy, Manal, Alahmadi, Ahlam A., Eid, Basma G., Neamatallah, Thikryat, Almukadi, Haifa S., Arab, Rana A., Faddladdeen, Khadija A., Al-Sulami, Khayria A., Bahshwan, Safia M., Ali, Soad S., Harakeh, Steve, Badr-Eldin, Shaimaa M.
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.01.2021
MDPI
Subjects
Online AccessGet full text
ISSN1660-4601
1661-7827
1660-4601
DOI10.3390/ijerph18010276

Cover

Abstract Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707). Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90–100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70–80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups.
AbstractList Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707). Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection ( p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90–100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70–80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups.
Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707). Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90–100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70–80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups.
Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707). Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90-100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70-80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups.Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707). Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90-100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70-80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups.
Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, = 726), and the other for the healthy people (Control group, = 707). The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection ( < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90-100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70-80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups.
Author Alahmadi, Ahlam A.
Almukadi, Haifa S.
Arab, Rana A.
Al-Sulami, Khayria A.
El-Shitany, Nagla A.
El-Hamamsy, Manal
Faddladdeen, Khadija A.
Badr-Eldin, Shaimaa M.
Harakeh, Steve
Eid, Basma G.
Ali, Soad S.
Bahshwan, Safia M.
Neamatallah, Thikryat
AuthorAffiliation 10 Special Infectious Agents Unit, King Fahd Medical Research Center, Yousef Abdullatif Jameel Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; sharakeh@gmail.com
1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; beid@kau.edu.sa (B.G.E.); Taneamatallah@kau.edu.sa (T.N.); hsalmukadi@kau.edu.sa (H.S.A.)
6 Medicine Program, Ibn Sina National Faculty for Medical Studies, Jeddah 22421, Saudi Arabia; charmingpearl1996@hotmail.com
3 Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; melhamamsy@kau.edu.sa
4 Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt
2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt
8 Department of Biology, Faculty of Science, Al-Baha University, Al-Baha 65511, Saudi Arabia; Safia_bahshw
AuthorAffiliation_xml – name: 8 Department of Biology, Faculty of Science, Al-Baha University, Al-Baha 65511, Saudi Arabia; Safia_bahshwan@yahoo.com
– name: 11 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Sbadr5@hotmail.com
– name: 4 Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt
– name: 7 Department of Biology, Faculty of Science and Arts in Al-Makhwah, Al-Baha University, Al-Baha 65511, Saudi Arabia; Alsulamikhayria@gmail.com
– name: 12 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
– name: 5 Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia; aahmadi1000@hotmail.com (A.A.A.); kfaddladdeen@kau.edu.sa (K.A.F.)
– name: 1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; beid@kau.edu.sa (B.G.E.); Taneamatallah@kau.edu.sa (T.N.); hsalmukadi@kau.edu.sa (H.S.A.)
– name: 3 Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; melhamamsy@kau.edu.sa
– name: 10 Special Infectious Agents Unit, King Fahd Medical Research Center, Yousef Abdullatif Jameel Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; sharakeh@gmail.com
– name: 6 Medicine Program, Ibn Sina National Faculty for Medical Studies, Jeddah 22421, Saudi Arabia; charmingpearl1996@hotmail.com
– name: 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt
– name: 9 Department of Histology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt; soadshaker@gmail.com
Author_xml – sequence: 1
  givenname: Nagla A.
  orcidid: 0000-0003-2593-6879
  surname: El-Shitany
  fullname: El-Shitany, Nagla A.
– sequence: 2
  givenname: Manal
  orcidid: 0000-0001-8822-5391
  surname: El-Hamamsy
  fullname: El-Hamamsy, Manal
– sequence: 3
  givenname: Ahlam A.
  surname: Alahmadi
  fullname: Alahmadi, Ahlam A.
– sequence: 4
  givenname: Basma G.
  surname: Eid
  fullname: Eid, Basma G.
– sequence: 5
  givenname: Thikryat
  orcidid: 0000-0002-2762-7108
  surname: Neamatallah
  fullname: Neamatallah, Thikryat
– sequence: 6
  givenname: Haifa S.
  surname: Almukadi
  fullname: Almukadi, Haifa S.
– sequence: 7
  givenname: Rana A.
  surname: Arab
  fullname: Arab, Rana A.
– sequence: 8
  givenname: Khadija A.
  surname: Faddladdeen
  fullname: Faddladdeen, Khadija A.
– sequence: 9
  givenname: Khayria A.
  surname: Al-Sulami
  fullname: Al-Sulami, Khayria A.
– sequence: 10
  givenname: Safia M.
  surname: Bahshwan
  fullname: Bahshwan, Safia M.
– sequence: 11
  givenname: Soad S.
  surname: Ali
  fullname: Ali, Soad S.
– sequence: 12
  givenname: Steve
  surname: Harakeh
  fullname: Harakeh, Steve
– sequence: 13
  givenname: Shaimaa M.
  surname: Badr-Eldin
  fullname: Badr-Eldin, Shaimaa M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33401440$$D View this record in MEDLINE/PubMed
BookMark eNp1Ustq3DAUFSUlr2bbZRF0041TydLIdheFidumA4GBJM1WyPJ1RoMsOZIdyIf0fyuTSUkCWemK89Dh6B6hPecdIPSRklPGKvLVbCEMG1oSSvJCvEOHVAiScUHo3rP5AB3FuCWElVxU--iAMU4o5-QQ_b3eAF71g9Ij9h1enq3xmfW-xefBT4Nxt9g7XK9vVj8yWuGbyToIqjHWjA9YuRZfQTB-ig5i_IaX-BLG4OMAejT3gOs0x-xqvnmnLK69S7C1kHTj1CaH3qcXxhRhmVwT3veTS9Yf0PtO2Qgnu_MY_fn187r-nV2sz1f18iLTnJZjRjsgVdnSQpCcC6YE0CLPO6EF1yzXtOug1VrppuRtw7qyIEwVgpdtIRrR8oodo--PvsPU9IkLKZ-ycgimV-FBemXkS8SZjbz197IoqgWnLBl82RkEfzdBHGVvogZrlYNUi8x5sVgwmpciUT-_om79FFItOxYVnM6JPj1P9D_K048lAn8k6LncAJ3UZlRzwSmgsZISOS-GfLkYSXb6Svbk_IbgHywsvO8
CitedBy_id crossref_primary_10_35516_jjps_v17i2_1978
crossref_primary_10_1002_hsr2_1498
crossref_primary_10_1002_rmv_2247
crossref_primary_10_2147_JMDH_S330958
crossref_primary_10_25259_JHAS_26_2023
crossref_primary_10_1007_s00709_022_01754_1
crossref_primary_10_1002_bies_202100158
crossref_primary_10_1016_j_tracli_2022_10_003
crossref_primary_10_1016_j_micpath_2022_105658
crossref_primary_10_4103_amit_amit_57_23
crossref_primary_10_1016_j_transci_2021_103321
Cites_doi 10.1016/j.meegid.2020.104485
10.1007/s00277-020-04348-0
10.1182/bloodadvances.2020002657
10.1038/s41467-020-19623-x
10.1016/j.nmni.2020.100763
10.30699/ijp.2020.125135.2367
10.1016/j.thromres.2020.04.013
10.1007/s00277-020-04169-1
10.1111/all.14238
10.1182/bloodadvances.2020002623
10.1128/CMR.00109-14
10.3389/fmed.2020.00491
10.1101/2020.07.17.20155986
10.1371/journal.pgen.1002480
10.3906/sag-2005-395
10.1177/0300060520949039
10.1161/ATVBAHA.119.313658
10.1111/vox.12786
10.1016/j.tracli.2020.08.009
10.3389/fcimb.2020.00404
10.1001/jama.2020.1585
10.1056/NEJMoa2001017
10.1021/acsnano.0c02624
10.1186/s43042-020-00097-x
10.1101/2020.04.15.20063107
10.1016/S0140-6736(20)30211-7
10.3201/eid2609.201932
10.1182/blood-2010-01-261859
10.3324/haematol.2020.266593
10.1093/glycob/cwn093
10.1056/NEJMoa2020283
10.1016/j.cytogfr.2020.05.009
10.1101/2020.01.31.929042
10.22541/au.160349176.67670206/v1
10.1128/JVI.00127-20
10.1101/2020.01.30.927806
10.1016/j.mehy.2020.110155
10.1111/vox.13004
10.3324/haematol.2020.265066
10.1101/2020.03.11.20031096
10.1136/gutjnl-2020-320926
10.1038/nature02145
10.1016/S0140-6736(20)30566-3
10.1056/NEJMoa2002032
10.3201/eid2607.200885
10.1111/bjh.16797
10.1111/irv.12758
10.1002/jmv.25725
10.1101/2020.06.13.20130211
10.1016/S0140-6736(20)30183-5
ContentType Journal Article
Copyright 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOI 10.3390/ijerph18010276
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
MEDLINE
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1660-4601
ExternalDocumentID PMC7795413
33401440
10_3390_ijerph18010276
Genre Journal Article
GeographicLocations Saudi Arabia
GeographicLocations_xml – name: Saudi Arabia
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
8R4
8R5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABGAM
ABUWG
ACGFO
ACGOD
ACIWK
ADBBV
AENEX
AFKRA
AFRAH
AFZYC
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBS
EJD
EMB
EMOBN
F5P
FYUFA
GX1
HH5
HMCUK
HYE
KQ8
L6V
M1P
M48
MODMG
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
Q2X
RNS
RPM
SV3
TR2
UKHRP
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PUEGO
7X8
ESTFP
5PM
ID FETCH-LOGICAL-c418t-1fe098d17602463a6e1722f6c64c32c1ffedccacb84db3f8703a7648d76b6d493
IEDL.DBID M48
ISSN 1660-4601
1661-7827
IngestDate Thu Aug 21 13:43:11 EDT 2025
Fri Sep 05 09:27:19 EDT 2025
Tue Sep 02 07:40:58 EDT 2025
Mon Jul 21 05:57:23 EDT 2025
Tue Jul 01 04:30:32 EDT 2025
Thu Apr 24 23:09:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
blood group
artificial respiration
oxygen saturation
myalgia
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c418t-1fe098d17602463a6e1722f6c64c32c1ffedccacb84db3f8703a7648d76b6d493
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2593-6879
0000-0001-8822-5391
0000-0002-2762-7108
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijerph18010276
PMID 33401440
PQID 2475516419
PQPubID 54923
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7795413
proquest_miscellaneous_2475531286
proquest_journals_2475516419
pubmed_primary_33401440
crossref_citationtrail_10_3390_ijerph18010276
crossref_primary_10_3390_ijerph18010276
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-01-01
20210101
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of environmental research and public health
PublicationTitleAlternate Int J Environ Res Public Health
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Flegel (ref_17) 2020; 105
Guo (ref_4) 2020; 26
ref_13
Anstee (ref_9) 2010; 115
Chen (ref_46) 2020; 395
ref_52
Wu (ref_14) 2020; 84
ref_19
Xia (ref_51) 2020; 92
ref_16
Ray (ref_20) 2020; 24
Fan (ref_25) 2020; 10
Barnkob (ref_27) 2020; 4
Malik (ref_2) 2020; 42
Wang (ref_45) 2020; 323
Jin (ref_53) 2020; 69
Ellinghaus (ref_15) 2020; 383
Taha (ref_30) 2020; 38
Latz (ref_35) 2020; 99
ref_22
Cooling (ref_36) 2015; 28
Gupta (ref_54) 2020; 90
Padhi (ref_29) 2020; 27
Guillon (ref_37) 2008; 18
Klok (ref_44) 2020; 191
Udugama (ref_8) 2020; 14
ref_26
Zietz (ref_33) 2020; 11
Huang (ref_48) 2020; 395
Lian (ref_47) 2020; 14
Oliveira (ref_10) 2020; 144
Groot (ref_11) 2020; 40
ref_34
ref_32
Zhan (ref_50) 2020; 48
Zhu (ref_5) 2020; 382
ref_39
Abdollahi (ref_31) 2020; 15
Hoiland (ref_21) 2020; 4
Gubernatorova (ref_42) 2020; 53
Zhou (ref_6) 2020; 395
Ayaz (ref_23) 2020; 50
Allami (ref_28) 2020; 21
Wan (ref_40) 2020; 94
Zhang (ref_1) 2020; 75
Li (ref_38) 2003; 426
ref_43
Du (ref_3) 2020; 26
Feng (ref_7) 2020; 7
ref_41
Li (ref_24) 2020; 190
Boudin (ref_18) 2020; 105
Stowell (ref_12) 2019; 114
ref_49
References_xml – volume: 84
  start-page: 104485
  year: 2020
  ident: ref_14
  article-title: Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis
  publication-title: Infect. Genet. Evol.
  doi: 10.1016/j.meegid.2020.104485
– ident: ref_26
  doi: 10.1007/s00277-020-04348-0
– volume: 4
  start-page: 4990
  year: 2020
  ident: ref_27
  article-title: Reduced prevalence of SARS-CoV-2 infection in ABO blood group O
  publication-title: Blood Adv.
  doi: 10.1182/bloodadvances.2020002657
– volume: 11
  start-page: 5761
  year: 2020
  ident: ref_33
  article-title: Associations between blood type and COVID-19 infection, intubation, and death
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19623-x
– volume: 38
  start-page: 100763
  year: 2020
  ident: ref_30
  article-title: Individuals with a Rh-positive but not Rh-negative blood group are more vulnerable to SARS-CoV-2 infection: Demographics and trend study on COVID-19 cases in Sudan
  publication-title: New Microbes New Infect.
  doi: 10.1016/j.nmni.2020.100763
– ident: ref_16
– volume: 90
  start-page: 193
  year: 2020
  ident: ref_54
  article-title: Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India
  publication-title: Monaldi Arch. Chest Dis.
– volume: 24
  start-page: m20-4511
  year: 2020
  ident: ref_20
  article-title: Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness
  publication-title: Ann. Intern. Med.
– volume: 15
  start-page: 156
  year: 2020
  ident: ref_31
  article-title: The novel coronavirus sars-cov-2 vulnerability association with abo/rh blood types
  publication-title: Iran. J. Pathol.
  doi: 10.30699/ijp.2020.125135.2367
– volume: 191
  start-page: 145
  year: 2020
  ident: ref_44
  article-title: Incidence of thrombotic complications in critically ill ICU patients with COVID-19
  publication-title: Thromb. Res.
  doi: 10.1016/j.thromres.2020.04.013
– volume: 99
  start-page: 2113
  year: 2020
  ident: ref_35
  article-title: Blood type and outcomes in patients with COVID-19
  publication-title: Ann. Hematol.
  doi: 10.1007/s00277-020-04169-1
– volume: 75
  start-page: 1730
  year: 2020
  ident: ref_1
  article-title: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
  publication-title: Allergy Eur. J. Allergy Clin. Immunol.
  doi: 10.1111/all.14238
– volume: 4
  start-page: 4981
  year: 2020
  ident: ref_21
  article-title: The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
  publication-title: Blood Adv.
  doi: 10.1182/bloodadvances.2020002623
– volume: 42
  start-page: 3
  year: 2020
  ident: ref_2
  article-title: Properties of Coronavirus and SARS-CoV-2—PubMed
  publication-title: Malays. J. Pathol.
– volume: 28
  start-page: 801
  year: 2015
  ident: ref_36
  article-title: Blood groups in infection and host susceptibility
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.00109-14
– volume: 7
  start-page: 491
  year: 2020
  ident: ref_7
  article-title: Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China
  publication-title: Front. Med.
  doi: 10.3389/fmed.2020.00491
– ident: ref_32
  doi: 10.1101/2020.07.17.20155986
– ident: ref_41
  doi: 10.1371/journal.pgen.1002480
– volume: 50
  start-page: 679
  year: 2020
  ident: ref_23
  article-title: The effects of blood group types on the risk of COVID-19 infection and its clinical outcome
  publication-title: Turk. J. Med. Sci.
  doi: 10.3906/sag-2005-395
– volume: 48
  start-page: 1
  year: 2020
  ident: ref_50
  article-title: Retrospective analysis of clinical characteristics of 405 patients with COVID-19
  publication-title: J. Int. Med. Res.
  doi: 10.1177/0300060520949039
– volume: 40
  start-page: 830
  year: 2020
  ident: ref_11
  article-title: Genetically determined ABO blood group and its associations with health and disease
  publication-title: Arter. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.119.313658
– volume: 114
  start-page: 535
  year: 2019
  ident: ref_12
  article-title: Biologic roles of the ABH and Lewis histo-blood group antigens part II: Thrombosis, cardiovascular disease and metabolism
  publication-title: Vox Sang.
  doi: 10.1111/vox.12786
– volume: 27
  start-page: 253
  year: 2020
  ident: ref_29
  article-title: ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population
  publication-title: Transfus. Clin. Biol.
  doi: 10.1016/j.tracli.2020.08.009
– volume: 10
  start-page: 404
  year: 2020
  ident: ref_25
  article-title: Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan
  publication-title: Front. Cell. Infect. Microbiol.
  doi: 10.3389/fcimb.2020.00404
– volume: 323
  start-page: 1061
  year: 2020
  ident: ref_45
  article-title: Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
  publication-title: JAMA
  doi: 10.1001/jama.2020.1585
– volume: 382
  start-page: 727
  year: 2020
  ident: ref_5
  article-title: A novel coronavirus from patients with pneumonia in China, 2019
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2001017
– volume: 14
  start-page: 3822
  year: 2020
  ident: ref_8
  article-title: Diagnosing COVID-19: The Disease and Tools for Detection
  publication-title: ACS Nano
  doi: 10.1021/acsnano.0c02624
– volume: 21
  start-page: 50
  year: 2020
  ident: ref_28
  article-title: Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients
  publication-title: Egypt. J. Med. Hum. Genet.
  doi: 10.1186/s43042-020-00097-x
– ident: ref_34
  doi: 10.1101/2020.04.15.20063107
– volume: 395
  start-page: 507
  year: 2020
  ident: ref_46
  article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30211-7
– volume: 26
  start-page: 2267
  year: 2020
  ident: ref_3
  article-title: Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2609.201932
– volume: 115
  start-page: 4635
  year: 2010
  ident: ref_9
  article-title: The relationship between blood groups and disease
  publication-title: Blood
  doi: 10.1182/blood-2010-01-261859
– volume: 105
  start-page: 2706
  year: 2020
  ident: ref_17
  article-title: COVID-19: Risk of infection is high, independently of ABO blood group
  publication-title: Haematologica
  doi: 10.3324/haematol.2020.266593
– volume: 18
  start-page: 1085
  year: 2008
  ident: ref_37
  article-title: Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwn093
– volume: 383
  start-page: 1522
  year: 2020
  ident: ref_15
  article-title: Genomewide Association Study of Severe Covid-19 with Respiratory Failure
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2020283
– volume: 53
  start-page: 13
  year: 2020
  ident: ref_42
  article-title: IL-6: Relevance for immunopathology of SARS-CoV-2
  publication-title: Cytokine Growth Factor Rev.
  doi: 10.1016/j.cytogfr.2020.05.009
– ident: ref_39
  doi: 10.1101/2020.01.31.929042
– ident: ref_22
  doi: 10.22541/au.160349176.67670206/v1
– volume: 94
  start-page: 127
  year: 2020
  ident: ref_40
  article-title: Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
  publication-title: J. Virol.
  doi: 10.1128/JVI.00127-20
– ident: ref_52
  doi: 10.1101/2020.01.30.927806
– volume: 144
  start-page: 110155
  year: 2020
  ident: ref_10
  article-title: The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions
  publication-title: Med. Hypotheses
  doi: 10.1016/j.mehy.2020.110155
– ident: ref_43
  doi: 10.1111/vox.13004
– volume: 105
  start-page: 2841
  year: 2020
  ident: ref_18
  article-title: ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults
  publication-title: Haematologica
  doi: 10.3324/haematol.2020.265066
– ident: ref_13
  doi: 10.1101/2020.03.11.20031096
– volume: 69
  start-page: 1002
  year: 2020
  ident: ref_53
  article-title: Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-320926
– volume: 426
  start-page: 450
  year: 2003
  ident: ref_38
  article-title: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
  publication-title: Nature
  doi: 10.1038/nature02145
– volume: 395
  start-page: 1054
  year: 2020
  ident: ref_6
  article-title: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30566-3
– ident: ref_49
  doi: 10.1056/NEJMoa2002032
– volume: 26
  start-page: 1586
  year: 2020
  ident: ref_4
  article-title: Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2607.200885
– volume: 190
  start-page: 24
  year: 2020
  ident: ref_24
  article-title: Association between ABO blood groups and risk of SARS-CoV-2 pneumonia
  publication-title: Br. J. Haematol.
  doi: 10.1111/bjh.16797
– volume: 14
  start-page: 564
  year: 2020
  ident: ref_47
  article-title: Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China
  publication-title: Influenza Other Respi. Viruses
  doi: 10.1111/irv.12758
– volume: 92
  start-page: 589
  year: 2020
  ident: ref_51
  article-title: Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.25725
– ident: ref_19
  doi: 10.1101/2020.06.13.20130211
– volume: 395
  start-page: 497
  year: 2020
  ident: ref_48
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
SSID ssj0038469
Score 2.361751
Snippet Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm...
Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between...
Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 276
SubjectTerms Age groups
Arabs
Blood Grouping and Crossmatching
Blood groups
Coronaviruses
COVID-19
COVID-19 - blood
COVID-19 - ethnology
Cross-Sectional Studies
Disease Susceptibility - blood
Disease transmission
Fever
Gender
Glycoproteins
Humans
Infections
Medical research
Morphology
Oxygen - blood
Oxygen saturation
Pandemics
Questionnaires
Retrospective Studies
Severe acute respiratory syndrome coronavirus 2
Social networks
Statistical analysis
Surveys and Questionnaires
Viral infections
Viruses
SummonAdditionalLinks – databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgXJAQonwulGqQkDhZXcdex-GCttsuLQcqAa16i2zHUYtWSelmD_0h_F9m7GTpguBsJ3E8nnnj8fgNY2-t00U9sYZPnFBcaVWgznnJDeqSl86Pfcq2-KyPTtWn88l5H3Bb9mmVg02MhrpqPcXI9zKV05mOEsWHqx-cqkbR6WpfQuMuuycQaWidm_nHwRJLxFZyfwViEEckzBNpo8Rt_t7l94D_IQxRqhHfyG1Q-svT_DNh8hYCzR-xh73rCNMk6212JzSP2YMUd4N0negJ-4lyh-N49RHaGqb7J7BPuekQg0yIU9A2MDs5Oz7gooCz1YJYp2OC7A3YpgKKlrWrJRnA9zCFL6G7bofbmDCj0fOvMXuLhjJLee6LgM8RTS3E0kWAPiWO0jrob590N0_Z6fzw2-yI96UXuFfCdFzUYVyYSuQaMVxLqwM6OlmtvVZeZl7UNU6Gt94ZVTlZo9JLm2tlqlw7XalCPmNbTduEFwxMQCPivVMisyoIYzPiLLMGPYtgVRVGjA9zX_qel5zKYyxK3J-QrMpNWY3Yu3X_q8TI8c-eO4Moy14zl-XvdTRib9bNqFN0UGKbgFOc-khEbnzF8yT59aekVLQJHY9YvrEm1h2Ir3uzpbm8iLzdeV5M0Gd4-f9hvWL3M8qbiWGeHbbVXa_Ca3R8OrcbV_cvmOgEng
  priority: 102
  providerName: ProQuest
Title The Impact of ABO Blood Grouping on COVID-19 Vulnerability and Seriousness: A Retrospective Cross-Sectional Controlled Study among the Arab Community
URI https://www.ncbi.nlm.nih.gov/pubmed/33401440
https://www.proquest.com/docview/2475516419
https://www.proquest.com/docview/2475531286
https://pubmed.ncbi.nlm.nih.gov/PMC7795413
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1fb9MwELfYJqFJCPF3FEZ1SEg8BerYtR0khNqwsiGxoUGnvkWO44ihKtm6VKIfhO_LXZIGCttLXnx2Tr473519_pmxlzZVUT60JhimXAZSyQhtzonAoC05kbqBa6otjtXhVH6aDWd_6p_aCby6NrWj96Smi_nrn5er92jw7yjjxJT9zfkPjzxxQ_BoWm2xHfRKihKxz7I7URDoZ6MGtPGaPrvsthCSkovBpn_6L-j8t3byL2c0ucfutlEkjBqx32e3fPGA3Wm24KC5WfSQ_UIVgKP6FiSUOYzGJzCmMnWo95vQZUFZQHxydvQh4BGcLecEQF3Xyq7AFhnQxlm5vKK18C2M4NRXi3J9MRNi4j74WhdyEStxU_I-99iPEGuhfsUIMLxELm0K7UWUavWITScH3-LDoH2FIXCSmyrguR9EJuNaoTtXwiqPMU-YK6ekE6HjeY6T4axLjcxSkaP9C6uVNJlWqcpkJB6z7aIs_BMGxuN64lwqeWil58aGBF9mDQYZ3srM91iwnvvEtRDl9FLGPMFUhcSWbIqtx1519BcNOMeNlPtrUSZrHUtCqemYUPKox150zWhedGZiC49T3NAIdOI4xF4j-e5Xa5XpMb2hEx0BQXdvthTn32sIb62jIYYPT28c8xnbDal6pt7s2Wfb1WLpn2P4U6V9tqVnGr8m5vSdfOyznfHB8ZfTfq3xvwGrHAoo
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELem8QASQnzTMeCQQDxZq2PXcZAQ6jqmlo1Ngm3qW-Y4jhiqkm1NhfqH8G_wN3KXL1YQvO3ZTuL4Pn2--x1jr2yio2xgDR8kQnGlVYQy5yQ3KEtOJq7v6myLAz0-Vh-ng-ka-9nWwlBaZasTK0WdFo5i5FuBCulOR4no_fkFp65RdLvattCo2WLPL7_jkW3-brKD9H0dBLsfjkZj3nQV4E4JU3KR-X5kUhFqNE9aWu3RhgeZdlo5GTiRZT7F33KJUWkiM-RnaUOtTBrqRKeKwJdQ5d9QFBlH-Qmn3QFPoi0nd1ugzeNoecMaJFLKqL919s3jvglDEG6Eb3LVCP7l2f6ZoHnF4u3eZXcaVxWGNW_dY2s-v89u13E-qMuXHrAfyGcwqUotochguH0I25QLD1VQC-0iFDmMDk8mO1xEcLKYEcp1lZC7BJunQNG5YjEnhfsWhvDZl5dFW_0JI1o9_1Jli9FSRnVe_czjcwSLC1WrJEAfFldpE2iqXcrlQ3Z8LUR5xNbzIvdPGBiPSsu5RInAKi-MDQgjzRr0ZLxVqe8x3u597BocdGrHMYvxPES0ildp1WNvuvnnNQLIP2dutqSMG00wj3_zbY-97IZRhulixuYet7ieI9FTwFc8rinffUpKRYfefo-FKzzRTSB88NWR_OxrhRMehtEAfZSN_y_rBbs5Pvq0H-9PDvaeslsB5exUIaZNtl5eLvwzdLrK5HnF6cBOr1u0fgGXuEGx
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemISEkhPhPYYCRQDxZrWPXdpAQ6lqqlaENAZv6ljmOI4aqZKypUD8IX4ZPx12chBUEb3u2kzi-vz7f_Y6Q5zZVcT60hg1TLplUMgaZc4IZkCUnUjdwIdviQO0dyXfz4XyL_GxrYTCtstWJtaLOSocx8n4kNd7pSB738yYt4sNk-ubsG8MOUnjT2rbTCCyy79ff4fi2fD2bAK1fRNH07efxHms6DDAnuakYz_0gNhnXCkyVElZ5sOdRrpySTkSO57nP4BddamSWihx4W1itpMm0SlUmEYgJ1P8VLcCrAlnS8-6wJ8Cuo-vNwf4xsMI6AEYKEQ_6p1897CE3COeGWCcXDeJfXu6fyZoXrN_0JrnRuK10FPjsFtnyxW1yPcT8aChlukN-AM_RWV12ScucjnYP6S7mxdM6wAU2kpYFHR8ezyaMx_R4tUDE6zo5d01tkVGM1JWrJSrfV3REP_rqvGwrQekYV88-1ZljuJRxyLFfeHgOIXJp3TaJgj8Lq7QpbSpfqvVdcnQpRLlHtouy8A8INR4UmHOp5JGVnhsbIV6aNeDVeCsz3yOs3fvENZjo2JpjkcDZCGmVbNKqR152888CGsg_Z-60pEwarbBMfvNwjzzrhkGe8ZLGFh62OMwR4DXAK-4HynefEkLiAXjQI3qDJ7oJiBW-OVKcfqkxw7WOh-CvPPz_sp6SqyBUyfvZwf4jci3C9J062rRDtqvzlX8M_leVPqkZnZKTy5asX3vRRfA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+ABO+Blood+Grouping+on+COVID-19+Vulnerability+and+Seriousness%3A+A+Retrospective+Cross-Sectional+Controlled+Study+among+the+Arab+Community&rft.jtitle=International+journal+of+environmental+research+and+public+health&rft.au=El-Shitany%2C+Nagla+A&rft.au=El-Hamamsy%2C+Manal&rft.au=Alahmadi%2C+Ahlam+A&rft.au=Eid%2C+Basma+G&rft.date=2021-01-01&rft.eissn=1660-4601&rft.volume=18&rft.issue=1&rft_id=info:doi/10.3390%2Fijerph18010276&rft_id=info%3Apmid%2F33401440&rft.externalDocID=33401440
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1660-4601&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1660-4601&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1660-4601&client=summon